The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition
about
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinomaGenetic and environmental influences on the prospective correlation between systemic inflammation and coronary heart disease death in male twins.Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis.Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In VivoModulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expressionNO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and diseaseSorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic miceTargeting PPARβ/δ for the treatment of type 2 diabetes mellitus.Transcriptional profiling identifies functional interactions of TGF β and PPAR β/δ signaling: synergistic induction of ANGPTL4 transcription.Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
P2860
Q34035095-3144D3F3-48E1-40E4-8914-36B050D02903Q34180517-E039967A-AD47-4FD9-A530-E3244413231EQ34399565-2A5393ED-2B1E-43EC-B6E3-61482737BA16Q35063224-3F34CC2B-300E-4B39-BECA-D48569A03548Q35613331-3905B242-97E3-4BE5-ADAC-06D50927FFD1Q35884894-2C9C3ED0-C0E4-41FF-ADC5-45A60092B9FEQ35961671-418C958F-C553-4CA4-B735-89111D4925B8Q36857534-94649136-44F0-45C8-B36E-BE63C9A03872Q37182798-D8B1F6DA-1827-43CE-A24B-99425EC98822Q37212217-402CAE4A-B2A7-4A6A-ABB0-ABE88A1AB18CQ37388607-42800825-DD13-4489-9A6E-8EAC68045882Q37583596-2B384516-3CCF-4159-BC36-92E7DE11D77EQ37613094-FA2153DD-12AD-4227-A145-921AF12BF841Q37978926-4C8ABBFF-01E9-4563-B8AE-8E45F232D00DQ38342835-006B4907-2E61-44AF-B04D-C1A57068847AQ38346897-50413653-F07D-46D7-B98E-EDA692BE9DF0Q38879903-C32178F0-B006-4A7C-A065-6D0EA7798489Q40095116-3A59A279-BCDE-412F-9632-3C05392068A3Q43136764-DDFB098E-FF7F-4F00-9FDF-EC60E1F4F383Q54657506-8323924F-78BB-443C-A77E-B95AEF0D0CE8
P2860
The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition
description
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/05/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/05/01)
@nl
наукова стаття, опублікована в травні 2007
@uk
مقالة علمية (نشرت في مايو 2007)
@ar
name
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@ast
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@en
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@nl
type
label
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@ast
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@en
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@nl
prefLabel
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@ast
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@en
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@nl
P2093
P2860
P1476
The PPARdelta agonist GW501516 ...... reaction via STAT3 inhibition
@en
P2093
G. P. Chrousos
K. C. Rice
P2860
P304
P356
10.1111/J.1365-2362.2007.01796.X
P577
2007-05-01T00:00:00Z